1 – 50 of 61
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Cumulative Absolute Risk of Subsequent Colorectal Cancer After Abdominopelvic Radiotherapy Among Childhood Cancer Survivors : A PanCareSurFup Study
(
- Contribution to journal › Article
- 2023
-
Mark
Clonal Hematopoiesis and Risk of Incident Lung Cancer
2023) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41(7). p.1423-1433(
- Contribution to journal › Article
-
Mark
Risk Factors for Heart Failure among Pan-European Childhood Cancer Survivors : A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study
(
- Contribution to journal › Article
-
Mark
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma with Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination
(
- Contribution to journal › Article
-
Mark
Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer
(
- Contribution to journal › Article
-
Mark
Chromosomal Gains as a Favorable Prognostic Factor in Pediatric ALL
(
- Contribution to journal › Article
-
Mark
Reply to V. Nardone et al
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Risk Factors for Primary Bone Cancer After Childhood Cancer : A PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies Nested Case-Control Study
2023) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41(21). p.3735-3746(
- Contribution to journal › Article
-
Mark
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival
2023) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41(10). p.1849-1863(
- Contribution to journal › Article
- 2022
-
Mark
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
(
- Contribution to journal › Article
-
Mark
Selumetinib Plus Adjuvant Radioactive Iodine in Patients with High-Risk Differentiated Thyroid Cancer : A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)
(
- Contribution to journal › Article
- 2021
-
Mark
Low-Dose Tamoxifen for Mammographic Density Reduction : A Randomized Controlled Trial
(
- Contribution to journal › Article
-
Mark
Burkitt Lymphoma International Prognostic Index
2021) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39(10). p.1129-1138(
- Contribution to journal › Article
-
Mark
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer : Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study
2021) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39(20). p.2294-2303(
- Contribution to journal › Article
-
Mark
ARTSCAN III : A randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck squamous cell cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Comment on "factors affecting sentinel node metastasis in thin (T1) cutaneous melanomas : Development and external validation of a predictive nomogram"
(
- Contribution to journal › Letter
-
Mark
Defining the mutational landscape of 3,217 primary breast cancer transcriptomes through large-scale RNA-seq within the Sweden Cancerome Analysis Network: Breast Project (SCAN-B; NCT03430492).
(
- Contribution to journal › Published meeting abstract
-
Mark
Cancer risks associated with germline PALB2 pathogenic variants : An international study of 524 families
(
- Contribution to journal › Article
- 2019
-
Mark
Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma : A Nordic Lymphoma Epidemiology Group Study
(
- Contribution to journal › Article
-
Mark
Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial
(
- Contribution to journal › Article
-
Mark
Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia : A Pooled Analysis of Individual Patient Data From Nine International Cohorts
(
- Contribution to journal › Article
-
Mark
Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia : A Retrospective Multinational Study
(
- Contribution to journal › Article
-
Mark
Effect of Radiotherapy After Breast-Conserving Surgery Depending on the Presence of Tumor-Infiltrating Lymphocytes : A Long-Term Follow-Up of the SweBCG91RT Randomized Trial
(
- Contribution to journal › Article
-
Mark
Clinicogenomic radiotherapy classifier predicting the need for intensified locoregional treatment after breast-conserving surgery for early-stage breast cancer
(
- Contribution to journal › Article
-
Mark
High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases : Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008
(
- Contribution to journal › Article
-
Mark
Cost effectiveness of interval cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in stage III ovarian cancer on the basis of a randomized phase III trial
(
- Contribution to journal › Article
- 2018
-
Mark
Tumor PIK3CA genotype and prognosis in early-stage breast cancer : A pooled analysis of individual patient data
(
- Contribution to journal › Article
-
Mark
Serum biomarker signature-based liquid biopsy for diagnosis of early-stage pancreatic cancer
(
- Contribution to journal › Article
-
Mark
Surveillance for late effects in childhood cancer survivors
(
- Contribution to journal › Scientific review
-
Mark
Models of care for survivors of childhood cancer from across the globe : Advancing survivorship care in the next decade
(
- Contribution to journal › Scientific review
-
Mark
High-dose chemotherapy and blood autologous stem-cell rescue compared with standard chemotherapy in localized high-risk ewing sarcoma : Results of Euro-E.W.I.N.G.99 and Ewing-2008
(
- Contribution to journal › Article
- 2017
-
Mark
Outcome of men with relapse after adjuvant carboplatin for clinical stage i seminoma
(
- Contribution to journal › Article
-
Mark
Distrust in the end-of-life care provided to a parent and long-term negative outcomes among bereaved adolescents : A population-based survey study
(
- Contribution to journal › Scientific review
-
Mark
Response to radiotherapy after breast-conserving surgery in different breast cancer subtypes in the Swedish Breast Cancer Group 91 radiotherapy randomized clinical trial
(
- Contribution to journal › Article
-
Mark
Cholesterol, cholesterol-lowering medication use, and breast cancer outcome in the BIG 1-98 study
(
- Contribution to journal › Article
-
Mark
International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma
(
- Contribution to journal › Article
-
Mark
Risk of second cancer in Hodgkin lymphoma survivors and influence of family history
(
- Contribution to journal › Article
-
Mark
Association of PET index quantifying skeletal uptake in NaF PET/CT images with overall survival in prostate cancer patients
2017) American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium In Journal of Clinical Oncology 35(6 Suppl). p.178-178(
- Contribution to journal › Published meeting abstract
-
Mark
Vasectomy and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)
(
- Contribution to journal › Article
-
Mark
Estimating the Risks of Breast Cancer Radiotherapy : Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials
2017) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 35(15). p.1641-1649(
- Contribution to journal › Article
- 2016
-
Mark
Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer : A report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup consortium
(
- Contribution to journal › Scientific review
-
Mark
Gain of 1q as a prognostic biomarker in Wilms Tumors (WTs) treated with preoperative chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 trial : A SIOP renal tumours biology consortium study
(
- Contribution to journal › Article
-
Mark
Randomized, double-blind, placebo-controlled phase III study of tasquinimod in men with metastatic castration-resistant prostate cancer
(
- Contribution to journal › Article
-
Mark
Double-blind, placebo-controlled, randomized phase III trial evaluating pertuzumab combined with chemotherapy for low tumor human epidermal growth factor receptor 3 mRNA-Expressing platinum-resistant ovarian Cancer (PENELOPE)
(
- Contribution to journal › Article
-
Mark
Two years of adjuvant tamoxifen provides a survival benefit compared with no systemic treatment in premenopausal patients with primary breast cancer : Long-Term follow-up (> 25 years) of the phase III SBII:2pre trial
(
- Contribution to journal › Article
- 2015
-
Mark
Evolution of Treatments for Peritoneal Metastases From Colorectal Cancer
2015) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 33(18). p.2122-2123(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Computer automated bone scan index (BSI) as an analytically validated imaging biomarker to quantitate change in bone scan of patients with metastatic prostate cancer
2015) American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium In Journal of Clinical Oncology 33(15 Suppl). p.5044-5044(
- Contribution to journal › Published meeting abstract
-
Mark
Quantitative imaging by automated bone scan index (BSI) as a response biomarker in standard clinical care of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide
2015) American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium In Journal of Clinical Oncology 33(7 Suppl). p.288-288(
- Contribution to journal › Published meeting abstract
- 2014
-
Mark
Development of novel metastatic prostate cancer cell lines by “organoid” in vitro culture technology.
(
- Contribution to journal › Article
- 2011
-
Mark
Gemcitabine Plus Docetaxel Versus Docetaxel in Patients With Predominantly Human Epidermal Growth Factor Receptor 2–Negative Locally Advanced or Metastatic Breast Cancer: A Randomized, Phase III Study by the Danish Breast Cancer Cooperative Group
(
- Contribution to journal › Article